ImageneBio (IMA) Total Liabilities (2020 - 2025)

ImageneBio has disclosed Total Liabilities across 6 years of filings, most recently posting $19.8 million for Q4 2025.

• Total Liabilities for Q4 2025 came in at $19.8 million, up 13.69% year-over-year; the trailing twelve-month figure through Dec 2025 was $19.8 million (up 13.69% YoY), and the FY2025 annual result was $19.8 million, up 13.69% from the prior year.
• Total Liabilities came in at $19.8 million for Q4 2025 at ImageneBio, down from $21.0 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $66.0 million in Q1 2021 to a low of $10.3 million in Q2 2025.
• The 5-year median for Total Liabilities is $21.7 million (2023), against an average of $28.3 million.
• Across the five-year window, Total Liabilities slumped 59.08% in 2023 and surged 42.63% in 2025, its largest moves.
• ImageneBio's Total Liabilities stood at $40.0 million in 2021, then slumped by 36.78% to $25.3 million in 2022, then fell by 11.68% to $22.3 million in 2023, then retreated by 21.88% to $17.4 million in 2024, then rose by 13.69% to $19.8 million in 2025.
• The last three Total Liabilities figures came in at $19.8 million (Q4 2025), $21.0 million (Q3 2025), and $10.3 million (Q2 2025), per Business Quant data.